Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alexander P. 2nd Gordon Hamilton Fairley lecture. Need for new approaches to the treatment of patients in clinical remission, with special reference to acute myeloid leukaemia. Br J Cancer. 1982 Aug;46(2):151–159. doi: 10.1038/bjc.1982.178. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Balkwill F. R., Moodie E. M., Freedman V., Fantes K. H. Human interferon inhibits the growth of established human breast tumours in the nude mouse. Int J Cancer. 1982 Aug 15;30(2):231–235. doi: 10.1002/ijc.2910300217. [DOI] [PubMed] [Google Scholar]
- Balkwill F., Taylor-Papadimitriou J., Fantes K. H., Sebesteny A. Human lymphoblastoid interferon can inhibit the growth of human breast cancer xenografts in athymic (nude) mice. Eur J Cancer. 1980 Apr;16(4):569–573. doi: 10.1016/0014-2964(80)90237-6. [DOI] [PubMed] [Google Scholar]
- DeGrado W. F., Wasserman Z. R., Chowdhry V. Sequence and structural homologies among type I and type II interferons. Nature. 1982 Nov 25;300(5890):379–381. doi: 10.1038/300379a0. [DOI] [PubMed] [Google Scholar]
- Forbes P., Dobbie D., Powles R., Alexander P. Maturation of human peripheral blood leukemic cells in short-term culture. Haematol Blood Transfus. 1981;26:268–271. doi: 10.1007/978-3-642-67984-1_46. [DOI] [PubMed] [Google Scholar]
- Millar J. L., Blackett N. M., Hudspith B. N. Enhanced post-irradiation recovery of the haemopoietic system in animals pretreated with a variety of cytotoxic agents. Cell Tissue Kinet. 1978 Sep;11(5):543–553. doi: 10.1111/j.1365-2184.1978.tb00826.x. [DOI] [PubMed] [Google Scholar]
- Palú G., Selby P., Powles R., Alexander P. Spontaneous regression of human acute myeloid leukaemia xenografts and phenotypic evidence for maturation. Br J Cancer. 1979 Nov;40(5):731–735. doi: 10.1038/bjc.1979.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Priestman T. J. Initial evaluation of human lymphoblastoid interferon in patients with advanced malignant disease. Lancet. 1980 Jul 19;2(8186):113–118. doi: 10.1016/s0140-6736(80)90004-5. [DOI] [PubMed] [Google Scholar]
- Rohatiner A. Z., Balkwill F. R., Griffin D. B., Malpas J. S., Lister T. A. A phase I study of human lymphoblastoid interferon administered by continuous intravenous infusion. Cancer Chemother Pharmacol. 1982;9(2):97–102. doi: 10.1007/BF00265387. [DOI] [PubMed] [Google Scholar]
- Selby P. J., Thomas J. M., Monaghan P., Sloane J., Peckham M. J. Human tumour xenografts established and serially transplanted in mice immunologically deprived by thymectomy, cytosine arabinoside and whole-body irradiation. Br J Cancer. 1980 Jan;41(1):52–61. doi: 10.1038/bjc.1980.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shorthouse A. J., Peckham M. J., Smyth J. F., Steel G. G. The therapeutic response of bronchial carcinoma xenografts: a direct patient-xenograft comparison. Br J Cancer Suppl. 1980 Apr;4:142–145. [PMC free article] [PubMed] [Google Scholar]
- Wetzel R., Perry L. J., Estell D. A., Lin N., Levine H. L., Slinker B., Fields F., Ross M. J., Shively J. Properties of a human alpha-interferon purified from E. coli extracts. J Interferon Res. 1981;1(3):381–390. doi: 10.1089/jir.1981.1.381. [DOI] [PubMed] [Google Scholar]
